NONINVASIVE DETECTION OF AR-FL/AR-V7 AS A PREDICTIVE BIOMARKER FOR THERAPEUTIC RESISTANCE IN MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
$600,000FY2015Department of DefenseDOD
Institute Of Cancer Research: Royal Cancer Hospital (The)
Institute Of Cancer Research: Royal Cancer Hospital (The)